(Q38125810)

29 August 2017

title

Probiotics and clinical effects: is the number what counts? (English)

1 reference

29 August 2017

0 references

Jacques Nicoli

4

0 references

Tore Midtvedt

series ordinal

3

object named as

Tore Midtvedt

1 reference

29 August 2017

5

Yolanda Sanz

1 reference

29 August 2017

Elisa Bertazzoni

1

1 reference

29 August 2017

Gianfranco Donelli

series ordinal

2

1 reference

29 August 2017

publication date

1 August 2013

1 reference

29 August 2017

published in

Journal of Chemotherapy

1 reference

29 August 2017

volume

25

1 reference

29 August 2017

issue

4

1 reference

29 August 2017

page(s)

193-212

1 reference

How host-microbial interactions shape the nutrient environment of the mammalian intestine

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Probiotics: Considerations for Human Health

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Survival of Lactobacillus casei in the human digestive tract after consumption of fermented milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Probiotics: immunomodulation and evaluation of safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Experimental effects of Saccharomyces boulardii on diarrheal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Probiotics promote gut health through stimulation of epithelial innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Probiotics and ileitis: could augmentation of TNF/NFκB activity be the answer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Probiotics and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Use of probiotics in children with acute diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Probiotic microbes: do they need to be alive to be beneficial?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Lactobacillus rhamnosus alleviates intestinal barrier dysfunction in part by increasing expression of zonula occludens-1 and myosin light-chain kinase in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Live and heat-killed Lactobacillus rhamnosus GG: effects on proinflammatory and anti-inflammatory cytokines/chemokines in gastrostomy-fed infant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Use of VSL[sharp]3 in the treatment of rotavirus diarrhea in children: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Management of acute diarrhoea with low osmolarity oral rehydration solutions and Lactobacillus strain GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Bifidobacterium longum PL03, Lactobacillus rhamnosus KL53A, and Lactobacillus plantarum PL02 in the prevention of antibiotic-associated diarrhea in children: a randomized controlled pilot trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Randomized, double-blind, placebo-controlled trial: effect of lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Meta-analysis: probiotics in antibiotic-associated diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Fecal microbiota transplantation: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Evidence-based guidelines for use of probiotics in preterm neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Guidelines for the management of inflammatory bowel disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Lactobacillus GG in inducing and maintaining remission of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Meta-analysis of probiotics for the treatment of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Effect of oral application of a probiotic E. coli strain on the intestinal microflora of children of allergic mothers during the first year of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Probiotics during weaning reduce the incidence of eczema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Immunomodulation of human blood cells following the ingestion of lactic acid bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Daily ingestion of fermented milk containing Lactobacillus casei DN114001 improves innate-defense capacity in healthy middle-aged people

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Aging of the human metaorganism: the microbial counterpart

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Intestinal bacteria and ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

The immunology of exceptional individuals: the lesson of centenarians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Probiotics and immunosenescence: cheese as a carrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Lactobacillus fermentum ME-3 - an antimicrobial and antioxidative probiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Probiotics improve bowel movements in hospitalized elderly patients--the PROAGE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Disposition kinetics of Saccharomyces boulardii in man and rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Saccharomyces boulardii'. A Review of an Innovative Biotherapeutic Agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

The probiotic effect of Saccharomyces boulardii in a pediatric age group

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Effects of feeding premature infants with Lactobacillus GG on gut fermentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Enteral feeding of premature infants with Lactobacillus GG

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Enteral feeding of premature infants with Saccharomyces boulardii

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Assessment of mucosal inflammation and blood flow in response to four weeks' intervention with probiotics in patients operated with a J-configurated ileal-pouch-anal-anastomosis (IPAA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Saccharomyces boulardii in maintenance treatment of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome--a double blind, placebo-controlled, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Probiotic supplementation in the first 6 months of life in at risk Asian infants - effects on eczema and atopic sensitization at the age of 1 year

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Failure of Synbiotic 2000 to prevent postoperative recurrence of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

A Randomized Formula Controlled Trial of Bifidobacterium lactis and Streptococcus thermophilus for Prevention of Antibiotic-Associated Diarrhea in Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

Immunomodulating potential of supplementation with probiotics: a doseâ response study in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000078

10.1179/1973947813Y.0000000078

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference